PALO ALTO, Calif., June 2, 2011 /PRNewswire/ — Jazz
Pharmaceuticals, Inc. (Nasdaq:
JAZZ) announced today that the company will make a presentation
at the Jefferies 2011 Global Healthcare Conference in New York on
Wednesday, June 8, 2011 at 9:30 a.m. Eastern Time. Bruce Cozadd,
the company’s chairman and chief executive officer, will provide a
A live webcast of presentation may be accessed from the
Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.
Please connect to the website prior to the start of the conference
call to ensure adequate time for any software downloads that may be
necessary to listen to the webcast.
An archived version of webcast will be available for at least
one week on the Investors section of the company’s website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq:
JAZZ) is a specialty pharmaceutical company that identifies,
develops and commercializes innovative treatments for important,
underserved markets in neurology and psychiatry. For further
information, see www.jazzpharmaceuticals.com.